S Green1, A Fortier, J Dijkstra
1EntreMed, Inc., Rockville, Maryland 20850, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Liposomes effectively deliver antigens for vaccines, demonstrating safety and efficacy in human trials. This technology holds promise for developing new vaccines against infectious, metabolic, and neoplastic diseases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: